Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/24 16:53 | 11/6/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | S | -246 | 36.76 | 0 | -7 | -20 | 27 | I | |||||||||||||||
10/28/24 16:41 | 10/25/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | S | -11 | 36.43 | 0 | 0 | -1 | 34 | I | |||||||||||||||
9/5/24 16:04 | 9/3/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S | -522 | 28.17 | 0 | -19 | -14 | 116 | D | ||||||||||||||
4/25/24 16:55 | 4/25/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | D | M.d | 0 | 0.00 | 0 | 3,640 | 306 | 4,830 | I | |||||||||||||||
8/25/22 19:37 | 8/25/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Souza Marcio | TX | D | P | 50 | 0.5608 | 0 | 90 | New | 90 | D | |||||||||||||||
6/10/22 18:24 | 6/8/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Hanley Jr. Michael Conick | TX | O | Chief Co | P | 20 | 0.7100 | 0 | 28 | 353 | 36 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |